Integer Holdings Corporation reported its financial results for the third quarter and first nine months of 2025, highlighting a revenue increase driven by strong demand and recent acquisitions. For the three months ended September 26, 2025, the company generated sales of $467.7 million, an increase of 8.4% from $431.4 million in the same period of 2024. For the nine months, sales rose to $1.38 billion, up 9.0% from $1.27 billion year-over-year. The gross profit for the third quarter was $126.2 million, reflecting a gross margin of 27.0%, consistent with the previous year, while the nine-month gross profit increased to $375.6 million, representing a gross margin of 27.2%.
The company’s operating income for the third quarter was $56.4 million, slightly down from $58.0 million in the prior year, while the nine-month operating income increased to $165.3 million from $151.2 million. Operating expenses rose to $69.7 million for the third quarter, up 19.1% from $58.6 million, primarily due to increased selling, general, and administrative expenses. Interest expenses decreased significantly, falling to $9.4 million for the third quarter from $14.6 million in the previous year, attributed to lower interest rates on outstanding borrowings.
Integer made strategic acquisitions during the reporting period, acquiring Precision Coating LLC and VSi Parylene, which are expected to enhance its service offerings in specialized coating technologies. The total consideration for these acquisitions was approximately $177.4 million, funded through borrowings under its revolving credit facility. The company also reported a significant increase in goodwill, which rose to $1.1 billion as of September 26, 2025, from $1.0 billion at the end of 2024, reflecting the impact of these acquisitions.
Operationally, Integer's customer base and product adoption rates showed positive trends, with sales from the Cardio & Vascular segment increasing by 15% in the third quarter. The company reported a current ratio of 3.71, indicating strong liquidity, and cash and cash equivalents increased to $58.9 million from $46.5 million at the end of 2024. The company’s outlook remains cautiously optimistic, with expectations of continued revenue growth driven by new product launches and market expansion, despite potential macroeconomic challenges.
About Integer Holdings Corp
Integer Holdings Corporation is a leading medical device contract manufacturer specializing in cardiac rhythm management, neuromodulation, and vascular markets. It develops and produces innovative components, sub-assemblies, and finished devices for OEMs worldwide. The company emphasizes high-quality, regulatory-compliant solutions, leveraging advanced technologies and strategic acquisitions to serve large healthcare providers and medical device companies in growth-oriented segments.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.